美国帕金森氏症脑深部刺激市场规模、份额和趋势分析报告：按产品、细分市场预测，2024-2030年

美国帕金森氏症脑深部刺激市场的成长和趋势

根据Grand View Research, Inc.最新报告，预计2030年美国帕金森氏症脑深部刺激市场规模将达到8.495亿美元，2024年至2030年复合年增长率为7.29%。

该市场受到新产品发布和医疗保健支出增加等多种因素的推动。增加监管核准是推动市场成长的关键，因为它为医疗保健专业人员和患者提供了有关这些设备的安全性和有效性的一定程度的保证，从而促进在临床实践中的采用发挥着重要作用。例如，2024 年 1 月，FDA 批准了 Abbott 的 Liberta RC DBS 设备，这是推动 PD治疗性介入介入的重要里程碑。

Liberta RC DBS 被认为是同类产品中最小的可充电 DBS 设备，并引入了显着的技术功能，例如支援远端程式设计功能的 NeuroSphere Virtual Clinical。此次监管核准强调了该设备遵守严格的安全性和有效性标准，并将其定位为神经调节领域的开创性解决方案。 Abbott 在 Liberta RC DBS 上纳入远端程式设计功能在策略上符合当前的医疗趋势，增加了患者的便利性并扩大了医疗界对该设备的接受度。

Abbott 最近 FDA 批准 Liberta RC DBS 预计将带来市场动态的变革，并推动美国DBS 领域对 PD 治疗的兴趣和采用。

美国帕金森氏症市场脑深部刺激报告亮点

• 预计从 2024 年到 2030 年，双通道细分市场的复合年增长率将达到 7.87%。
• 这一增长得益于行业主要企业的技术进步和新产品的推出。
• 推动市场成长的主要因素之一是监管机构越来越多地核准用于帕金森氏症 (PD) 治疗的深部脑部刺激 (DBS) 设备。
• 监管部门的核准为製造商提供了行销和商业化其设备的机会，并增加了竞争。
• 这种竞争可能会带来技术进步和设备设计的改进，从而带来更具成本效益的选择，进一步促进市场成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国帕金森氏症市场的深部脑部刺激变数、趋势和范围

• 市场体系展望
  • 配套市场前景
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• 美国巴金森氏症脑深部刺激市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析

第四章美国帕金森氏症脑深部刺激市场：产品预估及趋势分析

• 细分仪表板
• 美国巴金森氏症脑深部刺激市场波动分析
• 2018-2030年美国巴金森氏症脑深部电刺激市场规模及趋势分析（分产品）
• 单通道
• 双通道

第五章竞争状况

• 市场参与企业分类
• 主要企业简介
  • ABBOTT
  • Medtronic
  • Boston Scientific Corporation
• 热图分析/企业市场分析
• 2023年企业市场占有率评估分析
• 其他主要市场参与者名单

U.S. Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The U.S. deep brain stimulation in parkinson's disease market size is anticipated to reach USD 849.50 million by 2030, registering a CAGR of 7.29% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by various factors, such as novel product launches, and rising healthcare expenditure. Increasing regulatory approvals play a crucial role in driving market growth as they provide a level of assurance to healthcare professionals and patients regarding the safety and efficacy of these devices, thereby encouraging their adoption in clinical practice. For instance, in January 2024, FDA clearance for Abbott's Liberta RC DBS Device represented a significant milestone in advancing therapeutic interventions for PD.

Liberta RC DBS, distinguished as the smallest rechargeable DBS device in its class, introduced notable technological features, such as the NeuroSphere Virtual Clinical, enabling remote programming capabilities. This regulatory endorsement underscored adherence of the device to stringent safety and efficacy standards and positioned it as a pioneering solution in the field of neuromodulation. The incorporation of remote programming capabilities in the Liberta RC DBS device by Abbott aligns strategically with prevailing healthcare trends, augmenting patient convenience and broadening the device's acceptance within the medical community.

Abbott's recent achievement of securing FDA clearance for Liberta RC DBS is anticipated to catalyze transformative shifts in market dynamics, propelling heightened interest and fostering increased adoption within the U.S. DBS sector for PD treatment.

U.S. Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

• The dual-channel segment is expected to register the fastest CAGR of 7.87% from 2024 to 2030
• This growth is attributed to technological advancements and novel product launches by industry key players
• One of the key factors driving the market growth is increasing regulatory approval for deep brain stimulation (DBS) devices in Parkinson's disease (PD) treatment
• Regulatory approvals offer opportunities for manufacturers to market and commercialize their devices, fostering competition
• This competition often results in technological advancements, device design improvements, and potentially more cost-effective options, which further contribute to market growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements In Deep Brain Stimulation Devices
    • 3.2.1.2. Increasing Prevalence Of Parkinson's Disease
    • 3.2.1.3. Government Funding For Research And Development
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complex Regulatory Framework
    • 3.2.2.2. Risk And Complications Associated With DBS Surgery
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Increasing Clinical Studies On DBS Assessments For Parkinson's Disease
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Alternatives For DBS System
• 3.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Deep Brain Stimulation In Parkinson's Disease Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Deep Brain Stimulation In Parkinson's Disease Market Movement Analysis
• 4.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Single-Channel
  • 4.4.1. Single-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Dual-Channel
  • 4.5.1. Dual-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Key Company Profiles
  • 5.2.1. ABBOTT
    • 5.2.1.1. Company Overview
    • 5.2.1.2. Financial Performance
    • 5.2.1.3. Service Benchmarking
    • 5.2.1.4. Strategic Initiatives
  • 5.2.2. Medtronic
    • 5.2.2.1. Company Overview
    • 5.2.2.2. Financial Performance
    • 5.2.2.3. Service Benchmarking
    • 5.2.2.4. Strategic Initiatives
  • 5.2.3. Boston Scientific Corporation
    • 5.2.3.1. Company Overview
    • 5.2.3.2. Financial Performance
    • 5.2.3.3. Service Benchmarking
    • 5.2.3.4. Strategic Initiatives
• 5.3. Heat Map Analysis/ Company Market Position Analysis
• 5.4. Estimated Company Market Share Analysis, 2023
• 5.5. List of Other Key Market Players

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. U.S. Deep Brain Stimulation In Parkinson's Disease Market, by Product, 2018 - 2030 (USD Million)
• Table 4. Participant's Overview
• Table 5. Financial Performance
• Table 6. Product Benchmarking
• Table 7. Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Deep Brain Stimulation In Parkinson's Disease Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Product Marketplace: Key Takeaways
• Fig. 14 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Single-channel, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Dual-channel, 2018 - 2030 (USD Million)